KHC Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Kraft Heinz Co (KHC) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The company's financial performance is weak, analysts have consistently lowered price targets, and hedge funds are selling. While technical indicators show some neutral-to-positive trends, the lack of strong positive catalysts and the challenging macroeconomic environment make this stock unsuitable for long-term investment at this time.
The MACD histogram is positive at 0.22 and expanding, suggesting a bullish momentum. RSI is neutral at 64.363, and moving averages are converging, indicating no strong trend. The stock is trading near its resistance level (R1: 23.4), with key support at 21.757. Overall, the technical indicators are mixed, with a slight bullish bias.
Oscar Mayer's launch of Maple Bourbon Bacon and JELL-O's innovative marketing with the JELL-OMETER could drive some brand engagement. However, these are minor catalysts with limited impact on the company's overall performance.
Analysts have consistently lowered price targets, citing muted volume growth, limited pricing power, and higher input costs. Hedge funds are selling heavily, with a 136.56% increase in selling activity last quarter. Additionally, the broader consumer packaged goods industry faces pressures from inflation, demand destruction, and adverse currency moves.
In Q4 2025, revenue dropped by 3.38% YoY to $6.35 billion. Net income plummeted by 69.45% YoY to $651 million, and EPS fell by 68.75% YoY to $0.55. Gross margin also declined to 33.07%, down 3.87% YoY. These figures indicate significant financial struggles and margin erosion.
Analysts have a generally negative outlook on KHC. Multiple firms, including BNP Paribas, UBS, Deutsche Bank, and JPMorgan, have lowered price targets, with the lowest being $18. The consensus highlights concerns about muted growth, inflationary pressures, and limited pricing power. Most ratings are Neutral or Underperform, reflecting a lack of confidence in the stock's near-term recovery.
